IRIS PubliCatt

Bacigalupo, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.441
EU - Europa 2.087
AS - Asia 1.332
AF - Africa 30
SA - Sud America 26
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.931
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.406
SE - Svezia 611
CN - Cina 565
IT - Italia 520
SG - Singapore 365
IE - Irlanda 185
DE - Germania 177
ID - Indonesia 155
FR - Francia 137
TR - Turchia 126
RU - Federazione Russa 88
FI - Finlandia 79
GB - Regno Unito 69
UA - Ucraina 62
PL - Polonia 56
IN - India 53
CA - Canada 27
BE - Belgio 21
CI - Costa d'Avorio 20
HK - Hong Kong 17
JP - Giappone 16
CZ - Repubblica Ceca 14
AU - Australia 11
AT - Austria 10
KR - Corea 10
NL - Olanda 10
BR - Brasile 8
ES - Italia 8
IR - Iran 8
MX - Messico 7
AR - Argentina 5
CH - Svizzera 5
CO - Colombia 5
DK - Danimarca 5
EG - Egitto 5
RO - Romania 5
CL - Cile 4
PT - Portogallo 4
TW - Taiwan 4
HU - Ungheria 3
PH - Filippine 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
DZ - Algeria 2
EC - Ecuador 2
EU - Europa 2
HR - Croazia 2
LI - Liechtenstein 2
MA - Marocco 2
NO - Norvegia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
EE - Estonia 1
GR - Grecia 1
IL - Israele 1
IM - Isola di Man 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MK - Macedonia 1
MY - Malesia 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
Totale 5.931
Salva come PNG Salva come JPEG
Città #
Chandler 555
Singapore 281
Dublin 183
Ashburn 167
Jakarta 152
Ann Arbor 119
Izmir 118
Wilmington 103
Nanjing 98
Milan 87
Rome 80
Beijing 79
San Mateo 73
Moscow 70
Jacksonville 69
Fairfield 65
Boston 59
Cattolica 56
Houston 53
Nanchang 53
Princeton 52
Warsaw 52
Florence 47
New York 42
Seattle 39
Dearborn 38
Lawrence 36
Redwood City 36
Marseille 34
Woodbridge 33
Boardman 32
Fuzhou 32
Helsinki 32
Los Angeles 32
Hebei 23
Bremen 22
Redmond 22
Cambridge 21
Kunming 21
Abidjan 20
Brussels 20
Chicago 20
Jiaxing 20
Shenyang 20
Munich 19
Changsha 18
Hangzhou 18
Lancaster 18
Paris 18
Guangzhou 17
Shanghai 17
Mountain View 16
Tianjin 16
Pune 15
Arezzo 13
Toronto 13
Hong Kong 12
Brno 11
Santa Clara 11
Turin 11
Washington 11
Lappeenranta 10
Bologna 9
London 9
Mcallen 9
Norwalk 9
Zhengzhou 9
Andover 8
Hefei 8
Seoul 8
Worcester 7
Edinburgh 6
Falkenstein 6
Frankfurt am Main 6
Ottawa 6
Phoenix 6
Augusta 5
Bogotá 5
Council Bluffs 5
Kiel 5
Lanzhou 5
Naples 5
Nuremberg 5
Nürnberg 5
Bagnacavallo 4
Catania 4
Clearwater 4
Colli del Tronto 4
Jinan 4
Karasawa 4
Modena 4
Napoli 4
Parma 4
Sant'Egidio alla Vibrata 4
São Paulo 4
Taipei 4
Tokyo 4
Amsterdam 3
Apo 3
Atlanta 3
Totale 3.737
Salva come PNG Salva come JPEG
Nome #
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: An open-label, multicentre, randomised, phase 3 trial 314
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies:uptade consensus recommendations of the European Society for Blood 220
Rabbit ATG/ATLG in preventing graft-versus-host disease after allogenic stem cell transplantation: consensus-besed recommendations by an international expert panel 172
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 86
Nasopharynxkarzinom in einem europäischen Gebiet mit geringer Inzidenz: Eine prospektive Beobachtungsanalyse der Kopf- und Hals-Studiengruppe der Italienischen Gesellschaft für Radioonkologie (AIRO) 81
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 78
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. 77
A closer look at permissive HLA mismatch 76
UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen 75
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 74
Alternative donor transplants for severe aplastic anemia: current experience 73
A Modified Post-Transplant Cyclophosphamide Regimen, for Unmanipulated Haploidentical Marrow Transplantation, in Acute Myeloid Leukemia: A Multicenter Study 73
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 72
Allogeneic Hemopoietic Stem Cell Transplants in Patients with Acute Myeloid Leukemia (AML) Prepared with Busulfan and Fludarabine (BUFLU) or Thiotepa, Busulfan, and Fludarabine (TBF): A Retrospective Study 71
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 69
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 69
Unrelated cord blood transplantation and post-transplant cyclophosphamide 67
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study 67
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide :does graft cell content have an impact on main clinical outcomes? 67
Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal 67
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 67
Bone marrow transplantation versus immunosuppressive therapy in patients with acquired severe aplastic anemia 66
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 64
Integrating transplantation with antibodies and genetically modified T-cell therapies 64
Wilms Tumor 1 Expression and Pre-emptive Immunotherapy in Patients with Acute Myeloid Leukemia Undergoing an Allogeneic Hemopoietic Stem Cell Transplantation 64
Unrelated cord blood transplantation and post-transplant cyclophosphamide 64
Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant 63
Matched and mismatched unrelated donor transplantation: is the outcome the same as for matched sibling donor transplantation? 62
Mismatched unrelated hematopoietic stem cell transplantation with post-transplant cyclophosphamide for high-risk acute myeloid leukemia 62
Clinical effects of driver somatic mutations on the outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem-cell transplantation 62
Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: Monocentric observational study and review of the literature 62
ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- And Long-term Outcomes 62
Clinical effects of driver somatic mutations on the outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem-cell transplantation 61
Bone marrow transplantation versus immunosuppressive therapy in patients with acquired severe aplastic anemia 61
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes? 61
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 61
Antithymocyte globulin in the conditioning regimen: why not? 60
Post-transplant cyclophosphamide-based haplo-identical transplantation as alternative to matched sibling or unrelated donor transplantation for non-Hodgkin lymphoma: A registry study by the European society for blood and marrow transplantation 59
Leukaemia relapse after allogeneic transplants for acute myeloid leukaemia: predictive role of WT1 expression 58
Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups 58
High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients 58
Allogeneic Transplant for Mycosis Fungoides in Patient with Wiskott-Aldrich Syndrome 58
Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome 57
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 57
Menstrual patterns, fertility and main pregnancy outcomes after allogeneic haematopoietic stem cell transplantation 56
Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation 55
Thiotepa-based versus total body irradiation-based myeloablative conditioning prior to allogeneic stem cell transplantation for acute myeloid leukaemia in first complete remission: A retrospective analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation 55
Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: A retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO) 54
Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: A report from the acute leukemia working party of the EBMT 53
Alternative donor transplants for severe aplastic anemia: Current experience 53
Long-term survival and late events after allogeneic stem cell transplantation from HLA-matched siblings for acute myeloid leukemia with myeloablative compared to reduced-intensity conditioning: a report on behalf of the acute leukemia working party of European group for blood and marrow transplantation 52
Nutritional status and quality of life in adults undergoing allogeneic hematopoietic stem cell transplantation 52
Failure to effectively treat chronic graft-versus-host disease: a strong call for prevention 51
Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis 51
CD34 selected cells for the treatment of poor graft function after allogeneic stem cell transplantation 51
RIC versus MAC UCBT in adults with AML: A report from Eurocord, the ALWP and the CTIWP of the EBMT 50
Graft versus host disease in unmanipulated haploidentical marrow transplantation with a modified post-transplant cyclophosphamide (PT-CY) regimen: an update on 425 patients 50
PURLs: Light therapy for nonseasonal major depressive disorder? 49
Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter study 49
Allogeneic stem cell transplantation for nonmalignant diseases 47
Post-transplant cyclophosphamide versus antithymocyte-globulin as graft versus host disease prophylaxis in haploidentical transplant 47
Efficacy of ibrutinib in late relapse chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation 47
Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient 47
Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis 46
A Modified Post-Transplant Cyclophosphamide Regimen, for Unmanipulated Haploidentical Marrow Transplantation, in Acute Myeloid Leukemia: A Multicenter Study 46
Reducing infectious complications after allogeneic stem cell transplant 45
Days alive outside hospital and readmissions in patients undergoing allogeneic transplants from identical siblings or alternative donors 45
Failure to effectively treat chronic graft-versus-host disease: A strong call for prevention 44
Long-term survival in a patient with head and neck paraganglioma treated with tailored modalities for 20 years: a case report 44
Time to surgery and pathologic complete response after neoadjuvant chemoradiation in rectal cancer: A population study on 2094 patients 44
Philadelphia chromosome-negative classical myeloproliferative neoplasms: Revised management recommendations from European LeukemiaNet 43
full donor chimerism after allogenic hematopoietic stem cells transplant for myelofibrosis the role of the conditioning regiment 43
Second haploidentical stem cell transplantation for primary graft failure 43
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 42
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All-Trans Retinoic Acid: A Monocentric Experience 42
First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012 40
Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation 39
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 39
HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide 38
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 38
HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide 36
Steroid treatment of acute graft-versus-host disease grade I: A randomized trial 36
Extending long term follow up of patient with acute myeloid leukemia after autologous stem cell transplantation: Disclosing late mortality and causes of death 35
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 33
How I treat acquired aplastic anemia 32
Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update. 32
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 31
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 31
Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT 31
Haploidentical bone marrow transplantation for AML in remission following TBF conditioning: a long-term follow up 31
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 29
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 28
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 24
The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation 24
Foscarnet treatment of cytomegalovirus infection in haploidentical or unrelated donor transplants 23
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All-Trans Retinoic Acid: A Monocentric Experience 22
Peripheral Blood Allogeneic Stem Cell Mobilization: Can We Predict a Suboptimal Mobilization? 22
Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir-exposed CMV-free population receiving PTCy 22
Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia 21
Acute graft versus host disease 1976-2020: reduced incidence and predictive factors 21
Totale 5.673
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.761
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020365 0 0 0 0 0 0 93 18 28 92 82 52
2020/2021400 43 51 7 17 54 37 18 9 59 24 64 17
2021/2022742 72 12 31 31 49 15 15 114 49 72 129 153
2022/20231.744 259 228 137 242 140 215 79 117 169 50 85 23
2023/20241.154 41 260 66 63 35 115 80 83 39 75 133 164
2024/2025753 74 84 208 118 184 85 0 0 0 0 0 0
Totale 6.173